rs796756333
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PVS1_ModeratePM2PP3_StrongPP5
The NM_024422.6(DSC2):c.943-1G>A variant causes a splice acceptor change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000497 in 1,610,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_024422.6 splice_acceptor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.943-1G>A | splice_acceptor_variant | ENST00000280904.11 | |||
DSC2 | NM_001406506.1 | c.514-1G>A | splice_acceptor_variant | ||||
DSC2 | NM_001406507.1 | c.514-1G>A | splice_acceptor_variant | ||||
DSC2 | NM_004949.5 | c.943-1G>A | splice_acceptor_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.943-1G>A | splice_acceptor_variant | 1 | NM_024422.6 | P1 | |||
DSC2 | ENST00000251081.8 | c.943-1G>A | splice_acceptor_variant | 1 | |||||
DSC2 | ENST00000648081.1 | c.514-1G>A | splice_acceptor_variant | ||||||
DSC2 | ENST00000682357.1 | c.514-1G>A | splice_acceptor_variant |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152050Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.00000343 AC: 5AN: 1458052Hom.: 0 Cov.: 31 AF XY: 0.00000276 AC XY: 2AN XY: 725220
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152050Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74276
ClinVar
Submissions by phenotype
not provided Pathogenic:5
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | DSC2: PM2, PS4:Moderate, PVS1:Moderate - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 18, 2024 | Not observed at significant frequency in large population cohorts (gnomAD); Canonical splice site variant predicted to result in an in-frame loss of the adjacent exon in a gene for which loss of function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 21606396, 25525159, 25616645, 30847666, 31402444, 23871674, 34135346, 33662488, 35819174, 25820315) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Oct 12, 2021 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Arrhythmogenic right ventricular dysplasia 11 Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | Feb 23, 2017 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Sep 21, 2015 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Cardiovascular phenotype Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2023 | The c.943-1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide upstream from coding exon 8 of the DSC2 gene. This alteration has been reported in an individual with arrhythmogenic right ventricular cardiomyopathy (ARVC) (Cox MG et al. Circulation, 2011 Jun;123:2690-700). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site and will result in the creation or strengthening of a novel splice acceptor site. In addition to the clinical data presented in the literature, alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Apr 05, 2022 | This variant causes a G>A nucleotide substitution at the canonical c.-1 position of the intron 7 splice acceptor site of the DSC2 gene. Splice site prediction tools suggest that this variant may have a significant impact on RNA splicing. One of the possible molecular consequences of this variant is an in-frame skipping of exon 8, resulting in a mutant protein lacking 45 amino acids from the extracellular domain of the DSC2 protein. Alternatively, a downstream AG at c.953_954 may be utilized for splicing, resulting in a transcript missing the first 12 nucleotides (4 amino acids) from the beginning of exon 8. To our knowledge, functional RNA and protein studies have not been reported for this variant. This variant has been reported in at least one Dutch individual affected with arrhythmogenic right ventricular cardiomyopathy (PMID: 21606396, 23871674, 25820315, 30847666, 31386562) and in an asymptomatic family member of the proband (PMID: 21606396). This variant has also been observed in an asymptomatic Australian individual aged 70 years and older without a history of cardiovascular events (PMID: 34135346). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at